ArticleiScience2025
Epidemiology and antimicrobial resistance of pathogens in granulomatous mastitis: A multicenter study in Guangdong, China.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An endocrine microbe immunity framework for granulomatous mastitis toward phenotype-oriented interpretation.iScience · 2026Review
- Three-year cumulative antibiogram of breast-associated secretion and drainage specimens in female patients in Syria (2022-2024): microbiologic spectrum, antimicrobial susceptibility, and annual MSSA trends.BMC microbiology · 2026Article
- Molecular Targeted Therapy for Chronic Non-Bacterial Mastitis: New Insights into Pathophysiology and Therapeutic Strategies.International journal of women's health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granulomatous lobular mastitis (GLM) and non-GLM occur worldwide; however, the pathogen prevalence and resistance vary regionally. Therefore, we conducted a retrospective analysis of 1,535 women with mastitis from five hospitals in Guangdong, China (2018-2023). GLM comprised 37.3%, concentrated at ages 25-34; nearly all GLM occurred in non-lactating women (555/573), whereas 52.4% of non-GLM presented during lactation. The GLM proportion rose from 29.2% to 47.5% during 2018-2023. The predominant pathogen in non-GLM was
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.